JPRN-UMIN000006172已完成1 期
Feasibility study of dose eslation and concentration in stereotactic body radiotherapy (SBRT) for lung tumors - Feasibility study of dose eslation and concentration in SBRT for lung tumors
Ofuna SBRT study group0 个研究点目标入组 15 人开始时间: 2011年8月16日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
The median follow-up duration was 22.0 (12.0-27.0) months. After 6 months post-SBRT, the respective number of RP Grade 0, 1 and 2 cases was 5, 9 and 1. In the Grade 2 RP patient, the image showed an organizing pneumonia pattern at 6.0 months post-SBRT. No other toxicity was found. At last follow-up, there was no evidence of recurrence of the treated tumors.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. apparent interstitial pneumonitis and fibrosis 2. active inflamation without oral drugs 3. double cancer 4. pregnancy 5. psychiatric disorder 6. steroid administration 7. oxygen administration 8. fever of 38.0 degrees centigrade or higher 9. narcotics administration for coughing
研究者
相似试验
已完成
2 期
Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisPsoriasisNCT00678210Pfizer197
终止
2 期
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic PatientsDiabetes Mellitus, Type 2NCT00900146Novartis556
已完成
2 期
Comparison Of 6 CP-690,550 Doses Vs.Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid ArthritisArthritis, RheumatoidNCT00413660Pfizer509
终止
3 期
Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderDepressionNCT01121536Cephalon867
撤回
2 期
A Phase 2 Extension of Study GCS-100-CS-4003Chronic Kidney DiseaseNCT02333955La Jolla Pharmaceutical Company